Products

DERM (by Skin Analytics)
Skin Analytics
Clinical Decision Support & Reference

See all 1 product →

About Skin Analytics

Skin Analytics is a British health technology company that specializes in AI-powered solutions for skin cancer detection and diagnosis. Their flagship product, DERM, is an autonomous AI system designed to analyze images of skin lesions, triage patients, and potentially reduce waiting times for skin cancer assessments. This makes it the world’s first AI medical device legally authorized to independently make clinical decisions on skin cancer without human oversight.

The company’s mission is to make early and accurate diagnosis accessible to everyone, aiming to improve outcomes for skin cancer patients and alleviate pressure on healthcare systems facing dermatologist shortages. Skin Analytics collaborates with the NHS and has deployed DERM in numerous sites across England, demonstrating its ability to reduce unnecessary face-to-face dermatology appointments by up to 95% and safely discharge a significant percentage of urgent referrals. The AI has shown high accuracy in ruling out melanoma, with a negative predictive value of 99.7% to 99.9%. Beyond skin cancer, Skin Analytics plans to expand its AI platform to cover all dermatology concerns and to scale its services internationally to markets experiencing similar specialist shortages, including Europe, Australia, and the US.

Focus Areas

AI in dermatology skin cancer detection teledermatology machine learning digital health

Business Intelligence

TechnologyCloud-based AI medical device (DERM) for analyzing dermoscopic images, integrated into a custom teledermatology platform.

What Physicians Need to Know

Specialization
Skin Analytics specializes in AI-powered solutions for early and accurate skin cancer detection, teledermatology, and digital health. Their core product, DERM, is an AI as a Medical Device (AIaMD) designed to triage skin lesions and support referral decisions.
Key Differentiators
Skin Analytics stands out as the world's first autonomous AI for cancer detection, holding the highest regulatory classification (EU MDR Class III CE mark) for AI in medicine, allowing for clinical decisions without human oversight. It is also the only AI medical device recommended by NICE for autonomous skin cancer triage in the NHS. Their technology, DERM, has been extensively used within the NHS, assessing over 230,000 patients and detecting more than 20,000 cancers.
Technology Stack
The company leverages deep learning and AI algorithms trained on a large dataset of skin cancer images to analyze dermoscopic images of skin lesions. Their DERM platform can be used with a smartphone and a dermoscopic lens attachment to capture clinical-quality images. They also offer DERM Zero, which enables autonomous clinical-grade skin cancer assessments using a standard smartphone without specialist equipment.
Impact & Outcomes
DERM has demonstrated a 99.9% Negative Predictive Value (NPV) for ruling out melanoma and a high sensitivity for detecting various skin cancers (98% for all skin cancer, 97% for melanoma, 98% for invasive melanoma, SCC, and BCC). It has helped NHS organizations avoid up to 95% of face-to-face urgent suspected cancer referrals in secondary care and can safely discharge 30-55% of benign cases without specialist oversight, freeing up consultant time.
Physician Tip

For physicians, Skin Analytics' DERM offers a robust tool for efficient and accurate skin cancer triage, reducing unnecessary referrals and freeing up specialist capacity for higher-risk cases. The autonomous nature of DERM, backed by Class III CE mark and NICE recommendation, provides a high level of confidence in its diagnostic capabilities. The ability to use standard smartphones with DERM Zero can significantly improve patient access and streamline workflows, especially in primary care and community settings. The platform's continuous post-market surveillance and transparent accuracy reporting further ensure its reliability and safety in clinical practice.

Skin Analytics' DERM platform is designed to be integrated into existing healthcare pathways, including teledermatology services. They have established partnerships with organizations like Affidea for broader European implementation, indicating their adaptability for integration into various clinical settings and health systems. While specific API details for direct EHR/EMR integration are not explicitly detailed for DERM, other AI skin analysis platforms often offer API and SDK solutions for seamless integration into health and beauty apps or telemedicine platforms.

Products by Skin Analytics

1 product in the directory

DERM (by Skin Analytics)
Skin Analytics
Clinical Decision Support & Reference

Videos

News, demos, and interviews about Skin Analytics.

Loading videos...

Videos load interactively. If none appear, search YouTube for Skin Analytics →

View all on YouTube

No press coverage or publications on file yet. Know of some? Suggest an edit →

Frequently Asked Questions

Skin Analytics employs a deep learning AI known as DERM, which analyzes dermatoscopic images to assess the risk of skin cancer. This technology is designed to be integrated into existing teledermatology pathways, allowing healthcare professionals to upload images for AI analysis and receive a risk assessment to aid in their diagnostic decisions.
Skin Analytics' AI has been rigorously tested and validated through extensive clinical trials and real-world data, demonstrating high sensitivity and specificity in detecting melanoma and other skin cancers. The company publishes its validation studies in peer-reviewed journals, providing transparency on its performance and accuracy.
Skin Analytics' products hold the necessary regulatory clearances, including CE Mark in Europe, and are actively pursuing further clearances in other major markets. The company adheres to stringent data privacy regulations like GDPR and HIPAA, implementing robust security measures to protect patient data throughout the entire process.
Skin Analytics typically offers a subscription-based pricing model, which can vary depending on the scale of implementation and specific organizational needs. They provide comprehensive support, including initial training for clinical staff, technical integration assistance, and ongoing customer service to ensure seamless adoption and utilization of their platform.
Skin Analytics has established partnerships with numerous NHS trusts and private healthcare providers, as well as collaborating with academic institutions for research and development. The company is committed to advancing AI in dermatology, with a vision to become a global leader in early skin cancer detection, demonstrating strong financial backing and a clear growth strategy.

Related Companies

LabSense AI (labsense.ai) is an AI-powered medical lab result interpreter designed to democratize medical literacy globally. The platform aims to help patients understand their lab results in plain language, regardless of their education level or location. It processes lab reports (PDF or photo uploads) and provides explanations for over 86 lab tests, including blood count, […]

Intelligent Medical Objects (IMO) Health is an AI-native clinical data intelligence company that provides a foundation for modern health tech use cases. They leverage a clinician-built ontology and intelligent knowledge graph to create accurate, interoperable, and AI-ready data at scale. IMO Health’s solutions are designed to transform fragmented clinical documentation into structured, contextualized data, which […]

Cloudphysician is a health-tech company that provides AI-powered solutions to transform patient care and safety in intensive care units (ICUs) and emergency departments. The company’s proprietary platform, RADAR, acts as an AI video co-pilot for clinicians, integrating live video, vital signs, and Electronic Medical Records (EMRs) to intelligently interpret events in real-time and guide care […]

Exo Imaging is a pioneering healthcare AI company dedicated to modernizing medical imaging through its high-performance handheld ultrasound platform and artificial intelligence. The company’s mission is to make high-quality, affordable, and easy-to-use medical imaging accessible to healthcare professionals worldwide, enabling them to make critical, real-time decisions that ultimately improve patient outcomes. Exo’s technology combines advances […]

The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to protecting health and saving lives worldwide. As part of Johns Hopkins University, it conducts extensive research, provides education, and engages in public health practice across a broad spectrum of disciplines. The school’s work often involves leveraging advanced analytical methods, including artificial […]

The Yale School of Medicine is a leading institution dedicated to advancing science and medicine through discovery, both in the laboratory and at the bedside. It focuses on educating and nurturing future leaders by cultivating a dynamic, inclusive community that promotes curiosity and critical inquiry in an environment of scientific rigor. The institution applies advanced […]

AI Tool Finder
AI-powered search. Results may not be comprehensive.